Evidence map›Paper›PMID 29957454›Full record

ArticleJournal of inorganic biochemistry2018

Magnetic resonance imaging contrast enhancement in vitro and in vivo by octanuclear iron-oxo cluster-based agents.

Soma Das, Kenia Parga, Indranil Chakraborty, Arthur D Tinoco, Yamixa Delgado, Paola M López, Lauren Fernández Vega, Yiannis Sanakis, Sukhen Ghosh, Jim Bankson and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of inorganic biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Soma DasDepartment of Chemistry and the Institute for Functional Nanomaterials, University of Puerto Rico, San Juan, PR 00931, USA.
Kenia PargaDepartment of Chemistry and the Institute for Functional Nanomaterials, University of Puerto Rico, San Juan, PR 00931, USA.
Indranil ChakrabortyDepartment of Chemistry and the Institute for Functional Nanomaterials, University of Puerto Rico, San Juan, PR 00931, USA.
Arthur D TinocoDepartment of Chemistry and the Institute for Functional Nanomaterials, University of Puerto Rico, San Juan, PR 00931, USA.
Yamixa DelgadoDepartment of Chemistry and the Institute for Functional Nanomaterials, University of Puerto Rico, San Juan, PR 00931, USA.
Paola M LópezDepartment of Chemistry and the Institute for Functional Nanomaterials, University of Puerto Rico, San Juan, PR 00931, USA.
Lauren Fernández VegaDepartment of Chemistry and the Institute for Functional Nanomaterials, University of Puerto Rico, San Juan, PR 00931, USA.
Yiannis SanakisInstitute of Nanoscience and Nanotechnology, NCSR "Demokritos", 15310 Ag. Paraskevi, Attiki, Greece.
Sukhen GhoshCenter for Molecular Imaging, Institute of Molecular Medicine, University of Texas, Health Science Center, Houston, TX 77030, USA.
Jim BanksonDepartments of Imaging Physics-Research, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.
Jim KlostergaardMolecular and Cellular Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: jimklostergaard111@gmail.com.
Ricardo González-MéndezDepartment of Radiological Sciences, University of Puerto Rico - School of Medicine, Medical Sciences Campus, San Juan, PR 00936-5067, USA.. Electronic address: ricardo.gonzalez7@upr.edu.
Raphael G RaptisDepartment of Chemistry and the Institute for Functional Nanomaterials, University of Puerto Rico, San Juan, PR 00931, USA. Electronic address: raphael.raptis@fiu.edu.
University of Puerto Rico System · PRThe University of Texas MD Anderson Cancer Center · USNational Centre of Scientific Research "Demokritos" · GRThe University of Texas Health Science Center at Houston · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
UPR/MDACC Partnership for Excellence in Cancer Research(Parent Grant U54 CA096297)U54CA096297 · NCI · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI SHARON Hermes GIORDANO, REYNOLD Eugenio LOPEZ-ENRIQUEZ · 2002 to 2026
$36.9M
X-RAY STUDY OF SYNTHETIC OXYGEN CARRIERS RELATED TO BIOLOGICAL SYSTEMSS06GM008102 · NIGMS · UNIVERSITY OF PUERTO RICO RIO PIEDRAS · PI ARCE, RAFAEL · 1989 to 2008
$23.8M
Development of Peptide-Conjugate Biomimics for Targeted Ti(IV)-Based Anticancer DSC1CA190504 · NCI · UNIVERSITY OF PUERTO RICO RIO PIEDRAS · PI TINOCO, ARTHUR DAVID · 2014 to 2017
$1.4M
NCI NIH HHS SC1 CA190504NCI NIH HHS U54 CA096297NIGMS NIH HHS S06 GM008102
6 · The paper itself

Abstract

A water-soluble octanuclear cluster, [Fe

Indexed as

Contrast MediaIronMagnetic Resonance ImagingOrganometallic CompoundsA549 CellsAnimalsBreast NeoplasmsChlorocebus aethiopsCOS CellsFemaleHeterograftsHumansMiceMice, NudeNeoplasm TransplantationContrast MediaIronOrganometallic CompoundsBreast cancerin vivo studyMolecular relaxivitiesMRIParamagnetic contrast agentPolynuclear iron complex

Identifiers

PMID29957454
PMCPMC6943819
OpenAlexW2811282833

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.